CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The OMEGA project investigates the mechanisms of progressive pulmonary fibrosis, focusing on the role of monocyte subtypes and interstitial lung abnormalities. By studying these elements from early to advanced stages, the project aims to identify therapeutic targets that can halt disease progression before it becomes i…
Progressive pulmonary fibrosis (PF) is a debilitating and incurable disease.
Scaring of the lung leads to respiratory failure and 50% of patients die 3-5 years after diagnosis.
Our understanding of the pathophysiology of PF is unfortunately limited to established and advanced stages when the extensive lung scaring is irreversible. OMEGA is designed to explore new mechanisms underlying PF progression, from early to advanced disease and propose therapies that timely target the disease, prior to be…
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, MUNCHEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Munchen
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
